ID
22465
Descripción
Study ID: 100273 Clinical Study ID: HS2100273 Study Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter 60-Day Study Comparing the Efficacy of Valtrex 1 Gram Once Daily vs. Placebo Once Daily in Reducing Viral Shedding in Immunocompetent Subjects with Recurrent HSV-2 Genital Herpes Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Herpes Genitalis Visit description: Genital Herpes Recurrences
Palabras clave
Versiones (1)
- 5/6/17 5/6/17 -
Subido en
5 de junio de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Genital Herpes Recurrences
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Genital Herpes Recurrences
Similar models
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Genital Herpes Recurrences
C0034897 (UMLS CUI-2)
C0019342 (UMLS CUI [1,2])
C0034897 (UMLS CUI [1,3])
C0221201 (UMLS CUI [2])
C0332563 (UMLS CUI [3])
C0849001 (UMLS CUI [2,1])
C0849002 (UMLS CUI [2,2])
C0849001 (UMLS CUI [1,2])
C0849002 (UMLS CUI [1,3])
C0947323 (UMLS CUI [1,2])
C0947323 (UMLS CUI [1,2])